Nagoya University   Nagoya University Hospital Center of National University Hospital for Infection Control

2015.4

名古屋大学大学院   医学系研究科 附属医学教育研究支援センター   特任助教

2015.4 - 2015.6

名古屋大学医学部附属病院   初期研修医

2013.4 - 2015.3

日本学術振興会　特別研究員DC1

2007.4 - 2009.3

Generalized Verrucosis on a Background of 3C Syndrome Treated With Subcutaneous IgG Supplementation Reviewed International journal

Fukaura, R; Terashima-Murase, C; Tanahashi, K; Sato, Y; Kawase, M; Kato, K; Akiyama, M

JAMA DERMATOLOGY   Vol. 159 ( 12 ) page： 1397 - 1399   2023.12

Giant condyloma of Buschke-Lowenstein in a Netherton syndrome patient, successfully treated with cryotherapy and intravenous immunoglobulin Reviewed International journal

Sawa, M; Murase, C; Yamada, N; Fukaura, R; Tetsuka, N; Sato, Y; Takeichi, T; Akiyama, M

JOURNAL OF DERMATOLOGY   Vol. 50 ( 9 ) page： E289 - E291   2023.9

Growth Transformation of B Cells by Epstein-Barr Virus Requires <i>IMPDH2</i> Induction and Nucleolar Hypertrophy Reviewed International journal

Sugimoto, A; Watanabe, T; Matsuoka, K; Okuno, Y; Yanagi, Y; Narita, Y; Mabuchi, S; Nobusue, H; Sugihara, E; Hirayama, M; Ide, T; Onouchi, T; Sato, Y; Kanda, T; Saya, H; Iwatani, Y; Kimura, H; Murata, T

MICROBIOLOGY SPECTRUM   Vol. 11 ( 4 ) page： e0044023   2023.8

Generation and purification of ACTH-secreting hPSC-derived pituitary cells for effective transplantation Reviewed International journal

Taga, S; Suga, H; Nakano, T; Kuwahara, A; Inoshita, N; Kodani, Y; Nagasaki, H; Sato, Y; Tsumura, Y; Sakakibara, M; Soen, M; Miwata, T; Ozaki, H; Kano, M; Watari, K; Ikeda, A; Yamanaka, M; Takahashi, Y; Kitamoto, S; Kawaguchi, Y; Miyata, T; Kobayashi, T; Sugiyama, M; Onoue, T; Yasuda, Y; Hagiwara, D; Iwama, S; Tomigahara, Y; Kimura, T; Arima, H

STEM CELL REPORTS   Vol. 18 ( 8 ) page： 1657 - 1671   2023.8

Epstein-Barr Virus BBLF1 Mediates Secretory Vesicle Transport to Facilitate Mature Virion Release Reviewed International journal

Uddin, MK; Watanabe, T; Arata, M; Sato, Y; Kimura, H; Murata, T

JOURNAL OF VIROLOGY   Vol. 97 ( 6 ) page： e0043723   2023.6

Comprehensive Analyses of Intraviral Epstein-Barr Virus Protein-Protein Interactions Hint Central Role of BLRF2 in the Tegument Network Reviewed International journal

Hara, Y; Watanabe, T; Yoshida, M; Al Masud, HMA; Kato, H; Kondo, T; Suzuki, R; Kurose, S; Uddin, MK; Arata, M; Miyagi, S; Yanagi, Y; Sato, Y; Kimura, H; Murata, T

JOURNAL OF VIROLOGY   Vol. 96 ( 14 ) page： e0051822   2022.7

Direct reprogramming of adult adipose-derived regenerative cells toward cardiomyocytes using six transcriptional factors Reviewed International journal

Narita, S; Unno, K; Kato, K; Okuno, Y; Sato, Y; Tsumura, Y; Fujikawa, Y; Shimizu, Y; Hayashida, R; Kondo, K; Shibata, R; Murohara, T

ISCIENCE   Vol. 25 ( 7 ) page： 104651   2022.7

Elderly-onset systemic Epstein-Barr virus-positive T-cell lymphoma of childhood Reviewed

Nishikubo, M; Hiramoto, N; Yamashita, D; Imoto, H; Sato, Y; Okuno, Y; Haga, H; Nannya, Y; Ogawa, S; Kimura, H; Ishikawa, T

PATHOLOGY INTERNATIONAL   Vol. 72 ( 7 ) page： 376 - 378   2022.7

EBV Exploits RNA m<SUP>6</SUP>A Modification to Promote Cell Survival and Progeny Virus Production During Lytic Cycle Reviewed International journal

Yanagi, Y; Watanabe, T; Hara, Y; Sato, Y; Kimura, H; Murata, T

FRONTIERS IN MICROBIOLOGY   Vol. 13   page： 870816   2022.6

PD-L1 upregulation by lytic induction of Epstein-Barr Virus Reviewed International journal

Yanagi, Y; Hara, Y; Mabuchi, S; Watanabe, T; Sato, Y; Kimura, H; Murata, T

VIROLOGY   Vol. 568   page： 31 - 40   2022.3

In Silico Analysis and Synthesis of Nafamostat Derivatives and Evaluation of Their Anti-SARS-CoV-2 Activity Reviewed International journal

Fujimoto, KJ; Hobbs, DCF; Umeda, M; Nagata, A; Yamaguchi, R; Sato, Y; Sato, A; Ohmatsu, K; Ooi, T; Yanai, T; Kimura, H; Murata, T

VIRUSES-BASEL   Vol. 14 ( 2 )   2022.2

RNAseq analysis identifies involvement of EBNA2 in PD-L1 induction during EBV infection of primary B cells Reviewed International journal

Yanagi, Y; Okuno, Y; Narita, Y; Watanabe, T; Sato, Y; Kanda, T; Kimura, H; Murata, T

CANCER SCIENCE   Vol. 113   page： 1662 - 1662   2022.2

A STING inhibitor suppresses EBV-induced B cell transformation and lymphomagenesis Reviewed International journal

Miyagi, S; Watanabe, T; Hara, Y; Arata, M; Uddin, MK; Mantoku, K; Sago, K; Yanagi, Y; Suzuki, T; Al Masud, HMA; Kawada, J; Nakamura, S; Miyake, Y; Sato, Y; Murata, T; Kimura, H

CANCER SCIENCE   Vol. 112 ( 12 ) page： 5088 - 5099   2021.12

Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation Reviewed International journal

Murata, T; Sugimoto, A; Inagaki, T; Yanagi, Y; Watanabe, T; Sato, Y; Kimura, H

VIRUSES-BASEL   Vol. 13 ( 12 )   2021.12

Deletion of Viral microRNAs in the Oncogenesis of Epstein-Barr Virus-Associated Lymphoma Reviewed International journal

Kimura, H; Okuno, Y; Sato, Y; Watanabe, T; Murata, T

FRONTIERS IN MICROBIOLOGY   Vol. 12   page： 667968   2021.7

RNAseq analysis identifies involvement of EBNA2 in PD-L1 induction during Epstein-Barr virus infection of primary B cells Reviewed International journal

Yanagi, Y; Okuno, Y; Narita, Y; Al Masud, HMA; Watanabe, T; Sato, Y; Kanda, T; Kimura, H; Murata, T

VIROLOGY   Vol. 557   page： 44 - 54   2021.5

Oncolytic activity of naturally attenuated herpes-simplex virus HF10 against an immunocompetent model of oral carcinoma Reviewed International journal

Takano, G; Esaki, S; Goshima, F; Enomoto, A; Hatano, Y; Ozaki, H; Watanabe, T; Sato, Y; Kawakita, D; Murakami, S; Murata, T; Nishiyama, Y; Iwasaki, S; Kimura, H

MOLECULAR THERAPY-ONCOLYTICS   Vol. 20   page： 220 - 227   2021.3

Role of Epstein-Barr Virus C Promoter Deletion in Diffuse Large B Cell Lymphoma Reviewed International journal

Mabuchi, S; Hijioka, F; Watanabe, T; Yanagi, Y; Okuno, Y; Al Masud, HMA; Sato, Y; Murata, T; Kimura, H

CANCERS   Vol. 13 ( 3 )   2021.2

Anti-tumor effect of IL2-expressing HSV amplicon vector and oncolytic virus HF10 Reviewed

Esaki, S; Goshima, F; Takano, G; Watanabe, T; Sato, Y; Murata, T; Kimura, H

CANCER SCIENCE   Vol. 112   page： 394 - 394   2021.2

Direct Evidence of Abortive Lytic Infection-Mediated Establishment of Epstein-Barr Virus Latency During B-Cell Infection Reviewed International journal

Inagaki, T; Sato, Y; Ito, J; Takaki, M; Okuno, Y; Yaguchi, M; Al Masud, HMA; Watanabe, T; Sato, K; Iwami, S; Murata, T; Kimura, H

FRONTIERS IN MICROBIOLOGY   Vol. 11   page： 575255   2021.1

Bursitis, Bacteremia, and Disseminated Infection of <i>Mycobacteroides</i> <i>(Mycobacterium) abscessus</i> subsp. <i>massiliense</i> Reviewed International journal

Oka, K; Morioka, H; Eguchi, M; Sato, Y; Tetsuka, N; Iguchi, M; Kanematsu, T; Fukano, H; Hoshino, Y; Kiyoi, H; Yagi, T

INTERNAL MEDICINE   Vol. 60 ( 18 ) page： 3041 - 3045   2021

Oncolytic activity of HF10 in head and neck squamous cell carcinomas. Reviewed International journal

Esaki S, Goshima F, Ozaki H, Takano G, Hatano Y, Kawakita D, Ijichi K, Watanabe T, Sato Y, Murata T, Iwata H, Shibamoto Y, Murakami S, Nishiyama Y, Kimura H

Cancer gene therapy   Vol. 27 ( 7-8 ) page： 585 - 598   2020.8

Number of concomitant drugs with thrombocytopenic adverse effects and the extent inflammatory response resolution are risk factors for thrombocytopenia in patients treated with linezolid for more than 14 days Reviewed International journal

Sato, Y; Iguchi, M; Kato, Y; Morioka, H; Hirabayashi, A; Tetsuka, N; Tomita, Y; Kato, D; Yamada, K; Kimura, H; Yagi, T

NAGOYA JOURNAL OF MEDICAL SCIENCE   Vol. 82 ( 3 ) page： 407 - 414   2020.8

Oncogenesis of CAEBV revealed: Intragenic deletions in the viral genome and leaky expression of lytic genes Reviewed International journal

Murata Takayuki, Okuno Yusuke, Sato Yoshitaka, Watanabe Takahiro, Kimura Hiroshi

REVIEWS IN MEDICAL VIROLOGY   Vol. 30 ( 2 ) page： e2095   2020.3

Antitumor activity of cyclin-dependent kinase inhibitor alsterpaullone in Epstein-Barr virus-associated lymphoproliferative disorders Reviewed International journal

Watanabe Takahiro, Sato Yoshitaka, Al Masud H. M. Abdullah, Takayama Masahiro, Matsuda Hiroki, Hara Yuya, Yanagi Yusuke, Yoshida Masahiro, Goshima Fumi, Murata Takayuki, Kimura Hiroshi

CANCER SCIENCE   Vol. 111 ( 1 ) page： 279 - 287   2020.1

[Dynamic changes of cellular environment during Epstein-Barr virus productive replication]. Invited

Sato Y

Uirusu   Vol. 70 ( 1 ) page： 83 - 90   2020

Epstein-Barr Virus BBRF2 Is Required for Maximum Infectivity Reviewed International journal

Al Masud H. M. Abdullah, Yanagi Yusuke, Watanabe Takahiro, Sato Yoshitaka, Kimura Hiroshi, Murata Takayuki

MICROORGANISMS   Vol. 7 ( 12 )   2019.12

The BOLF1 gene is necessary for effective Epstein-Barr viral infectivity. Reviewed International journal

Masud HMAA, Watanabe T, Sato Y, Goshima F, Kimura H, Murata T

Virology   Vol. 531   page： 114 - 125   2019.5

Initial Characterization of the Epstein-Barr Virus BSRF1 Gene Product Reviewed International journal

Yanagi Yusuke, Al Masud H. M. Abdullah, Watanabe Takahiro, Sato Yoshitaka, Goshima Fumi, Kimura Hiroshi, Murata Takayuki

VIRUSES-BASEL   Vol. 11 ( 3 )   2019.3

Defective Epstein-Barr virus in chronic active infection and haematological malignancy. Reviewed International journal

Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T, Okuno T, Murakami N, Yoshida K, Sawada A, Inoue M, Kawa K, Seto M, Ohshima K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Narita Y, Yoshida M, Goshima F, Kawada JI, Nishida T, Kiyoi H, Kato S, Nakamura S, Morishima S, Yoshikawa T, Fujiwara S, Shimizu N, Isobe Y, Noguchi M, Kikuta A, Iwatsuki K, Takahashi Y, Kojima S, Ogawa S, Kimura H

Nature microbiology   Vol. 4 ( 3 ) page： 404 - 413   2019.3

Challenges in Managing EBV-Associated T- and NK-Cell Lymphoproliferative Diseases Reviewed International journal

Sato Yoshitaka

FRONTIERS IN PEDIATRICS   Vol. 6   page： 320   2018.11

Regulation of Epstein-Barr Virus Life Cycle and Cell Proliferation by Histone H3K27 Methyltransferase EZH2 in Akata Cells Reviewed International journal

Ichikawa Takaya, Okuno Yusuke, Sato Yoshitaka, Goshima Fumi, Yoshiyama Hironori, Kanda Teru, Kimura Hiroshi, Murata Takayuki

MSPHERE   Vol. 3 ( 6 )   2018.11

Antitumor effects of duvelisib on Epstein-Barr virus-associated lymphoma cells. Reviewed International journal

Kawada JI, Ando S, Torii Y, Watanabe T, Sato Y, Ito Y, Kimura H

Cancer medicine   Vol. 7 ( 4 ) page： 1275 - 1284   2018.4

BGLF2 Increases Infectivity of Epstein-Barr Virus by Activating AP-1 upon De Novo Infection Reviewed International journal

Konishi Natsuno, Narita Yohei, Hijioka Fumiya, Al Masud H. M. Abdullah, Sato Yoshitaka, Kimura Hiroshi, Murata Takayuki

MSPHERE   Vol. 3 ( 2 )   2018.3

Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production. Reviewed International journal

Masud HMAA, Watanabe T, Yoshida M, Sato Y, Goshima F, Kimura H, Murata T

Journal of virology   Vol. 91 ( 23 )   2017.12

Characterization of a Suppressive <i>Cis</i>-acting Element in the Epstein-Barr Virus LMP1 Promoter. Reviewed International journal

Yoshida M, Murata T, Ashio K, Narita Y, Watanabe T, Masud HMAA, Sato Y, Goshima F, Kimura H

Frontiers in microbiology   Vol. 8   page： 2302   2017.11

The Epstein-Barr Virus BRRF1 Gene Is Dispensable for Viral Replication in HEK293 cells and Transformation. Reviewed International journal

Yoshida M, Watanabe T, Narita Y, Sato Y, Goshima F, Kimura H, Murata T

Scientific reports   Vol. 7 ( 1 ) page： 6044   2017.7

Elimination of LMP1-expressing cells from a monolayer of gastric cancer AGS cells. Reviewed International journal

Sato Y, Ochiai S, Murata T, Kanda T, Goshima F, Kimura H

Oncotarget   Vol. 8 ( 24 ) page： 39345 - 39355   2017.6

The C-Terminus of Epstein-Barr Virus BRRF2 Is Required for its Proper Localization and Efficient Virus Production. Reviewed International journal

Watanabe T, Sakaida K, Yoshida M, Masud HM, Sato Y, Goshima F, Kimura H, Murata T

Frontiers in microbiology   Vol. 8   page： 125   2017.1

The efficacy of combination therapy with oncolytic herpes simplex virus HF10 and dacarbazine in a mouse melanoma model. Reviewed

Tanaka R, Goshima F, Esaki S, Sato Y, Murata T, Nishiyama Y, Watanabe D, Kimura H

American journal of cancer research   Vol. 7 ( 8 ) page： 1693 - 1703   2017

The efficacy of combination therapy with oncolytic herpes simplex virus HF10 and dacarbazine in a mouse melanoma model Reviewed

Tanaka Rui, Goshima Fumi, Esaki Shinichi, Sato Yoshitaka, Murata Takayuki, Nishiyama Yukihiro, Watanabe Daisuke, Kimura Hiroshi

AMERICAN JOURNAL OF CANCER RESEARCH   Vol. 7 ( 8 ) page： 1693-1703   2017

Tofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells. Reviewed

Ando S, Kawada JI, Watanabe T, Suzuki M, Sato Y, Torii Y, Asai M, Goshima F, Murata T, Shimizu N, Ito Y, Kimura H

Oncotarget   Vol. 7 ( 47 ) page： 76793-76805   2016.11

Induction of Epstein-Barr Virus Oncoprotein LMP1 by Transcription Factors AP-2 and Early B Cell Factor. Reviewed

Murata T, Noda C, Narita Y, Watanabe T, Yoshida M, Ashio K, Sato Y, Goshima F, Kanda T, Yoshiyama H, Tsurumi T, Kimura H

Journal of virology   Vol. 90 ( 8 ) page： 3873-89   2016.4

Induction of Epstein-Barr Virus Oncoprotein Latent Membrane Protein 1 (LMP1) by Transcription Factors Activating Protein 2 (AP-2) and Early B Cell Factor (EBF) Reviewed

Takayuki Murata, Chieko Noda, Yohei Narita, Takahiro Watanabe, Masahiro Yoshida, Keiji Ashio, Yoshitaka Sato, Fumi Goshima, Teru Kanda, Hironori Yoshiyama, Tatsuya Tsurumi, and Hiroshi Kimura

Journal of Virology   Vol. 90   page： 3873-3889   2016

The Epstein-Barr Virus BDLF4 Gene Is Required for Efficient Expression of Viral Late Lytic Genes. Reviewed

Watanabe T, Narita Y, Yoshida M, Sato Y, Goshima F, Kimura H, Murata T

Journal of virology   Vol. 89 ( 19 ) page： 10120-4   2015.10

Anti-CCR4 monoclonal antibody mogamulizumab for the treatment of EBV-associated T- and NK-cell lymphoproliferative diseases. Reviewed

Kanazawa T, Hiramatsu Y, Iwata S, Siddiquey M, Sato Y, Suzuki M, Ito Y, Goshima F, Murata T, Kimura H

Clinical cancer research : an official journal of the American Association for Cancer Research   Vol. 20 ( 19 ) page： 5075-84   2014.10

Role of latent membrane protein 1 in chronic active Epstein-Barr virus infection-derived T/NK-cell proliferation. Reviewed

Ito T, Kawazu H, Murata T, Iwata S, Arakawa S, Sato Y, Kuzushima K, Goshima F, Kimura H

Cancer medicine   Vol. 3 ( 4 ) page： 787-95   2014.8

Modes of infection and oncogenesis by the Epstein-Barr virus. Reviewed

Murata T, Sato Y, Kimura H

Reviews in medical virology   Vol. 24 ( 4 ) page： 242-53   2014.7

Genome guardian p53 and viral infections. Reviewed

Sato Y, Tsurumi T

Reviews in medical virology   Vol. 23 ( 4 ) page： 213-20   2013.7

Different distributions of Epstein-Barr virus early and late gene transcripts within viral replication compartments. Reviewed

Sugimoto A, Sato Y, Kanda T, Murata T, Narita Y, Kawashima D, Kimura H, Tsurumi T

Journal of virology   Vol. 87 ( 12 ) page： 6693-9   2013.6

Mitochondrial defect drives non-autonomous tumour progression through Hippo signalling in Drosophila. Reviewed

Ohsawa S, Sato Y, Enomoto M, Nakamura M, Betsumiya A, Igaki T

Nature   Vol. 490 ( 7421 ) page： 547-51   2012.10

Noise cancellation: viral fine tuning of the cellular environment for its own genome replication. Reviewed

Sato Y, Tsurumi T

PLoS pathogens   Vol. 6 ( 12 ) page： e1001158   2010.12

Transient increases in p53-responsible gene expression at early stages of Epstein-Barr virus productive replication. Reviewed

Sato Y, Shirata N, Murata T, Nakasu S, Kudoh A, Iwahori S, Nakayama S, Chiba S, Isomura H, Kanda T, Tsurumi T

Cell cycle (Georgetown, Tex.)   Vol. 9 ( 4 ) page： 807-14   2010.2

Epstein-Barr virus polymerase processivity factor enhances BALF2 promoter transcription as a coactivator for the BZLF1 immediate-early protein. Invited Reviewed

Nakayama S, Murata T, Murayama K, Yasui Y, Sato Y, Kudoh A, Iwahori S, Isomura H, Kanda T, Tsurumi T

The Journal of biological chemistry   Vol. 284 ( 32 ) page： 21557-68   2009.8

Phosphorylation of p27Kip1 by Epstein-Barr virus protein kinase induces its degradation through SCFSkp2 ubiquitin ligase actions during viral lytic replication. Reviewed

Iwahori S, Murata T, Kudoh A, Sato Y, Nakayama S, Isomura H, Kanda T, Tsurumi T

The Journal of biological chemistry   Vol. 284 ( 28 ) page： 18923-31   2009.7

Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex. Reviewed

Sato Y, Kamura T, Shirata N, Murata T, Kudoh A, Iwahori S, Nakayama S, Isomura H, Nishiyama Y, Tsurumi T

PLoS pathogens   Vol. 5 ( 7 ) page： e1000530   2009.7

Homologous recombinational repair factors are recruited and loaded onto the viral DNA genome in Epstein-Barr virus replication compartments. Reviewed

Kudoh A, Iwahori S, Sato Y, Nakayama S, Isomura H, Murata T, Tsurumi T

Journal of virology   Vol. 83 ( 13 ) page： 6641-51   2009.7

Efficient production of infectious viruses requires enzymatic activity of Epstein-Barr virus protein kinase. Reviewed

Murata T, Isomura H, Yamashita Y, Toyama S, Sato Y, Nakayama S, Kudoh A, Iwahori S, Kanda T, Tsurumi T

Virology   Vol. 389 ( 1-2 ) page： 75-81   2009.6

Expression of Epstein-Barr virus BZLF1 immediate-early protein induces p53 degradation independent of MDM2, leading to repression of p53-mediated transcription. Reviewed

Sato Y, Shirata N, Kudoh A, Iwahori S, Nakayama S, Murata T, Isomura H, Nishiyama Y, Tsurumi T

Virology   Vol. 388 ( 1 ) page： 204-11   2009.5

TORC2, a coactivator of cAMP-response element-binding protein, promotes Epstein-Barr virus reactivation from latency through interaction with viral BZLF1 protein. Reviewed

Murata T, Sato Y, Nakayama S, Kudoh A, Iwahori S, Isomura H, Tajima M, Hishiki T, Ohshima T, Hijikata M, Shimotohno K, Tsurumi T

The Journal of biological chemistry   Vol. 284 ( 12 ) page： 8033-41   2009.3

Identification of phosphorylation sites on transcription factor Sp1 in response to DNA damage and its accumulation at damaged sites. Reviewed

Iwahori S, Yasui Y, Kudoh A, Sato Y, Nakayama S, Murata T, Isomura H, Tsurumi T

Cellular signalling   Vol. 20 ( 10 ) page： 1795-803   2008.10

Noncanonical TATA sequence in the UL44 late promoter of human cytomegalovirus is required for the accumulation of late viral transcripts. Reviewed

Isomura H, Stinski MF, Kudoh A, Murata T, Nakayama S, Sato Y, Iwahori S, Tsurumi T

Journal of virology   Vol. 82 ( 4 ) page： 1638-46   2008.2

A cis element between the TATA Box and the transcription start site of the major immediate-early promoter of human cytomegalovirus determines efficiency of viral replication. Reviewed

Isomura H, Stinski MF, Kudoh A, Nakayama S, Murata T, Sato Y, Iwahori S, Tsurumi T

Journal of virology   Vol. 82 ( 2 ) page： 849-58   2008.1

Enhanced phosphorylation of transcription factor sp1 in response to herpes simplex virus type 1 infection is dependent on the ataxia telangiectasia-mutated protein. Reviewed

Iwahori S, Shirata N, Kawaguchi Y, Weller SK, Sato Y, Kudoh A, Nakayama S, Isomura H, Tsurumi T

Journal of virology   Vol. 81 ( 18 ) page： 9653-64   2007.9

The late promoter of the human cytomegalovirus viral DNA polymerase processivity factor has an impact on delayed early and late viral gene products but not on viral DNA synthesis. Reviewed

Isomura H, Stinski MF, Kudoh A, Nakayama S, Iwahori S, Sato Y, Tsurumi T

Journal of virology   Vol. 81 ( 12 ) page： 6197-206   2007.6

Sumoylation of CCAAT/enhancer-binding protein alpha and its functional roles in hepatocyte differentiation. Reviewed

Sato Y, Miyake K, Kaneoka H, Iijima S

The Journal of biological chemistry   Vol. 281 ( 31 ) page： 21629-39   2006.8

Identification of cis-acting regions that contribute to neuron-specific expression of the GAP-43 gene. Reviewed

Takahashi M, Sato Y, Nakagami Y, Miyake K, Iijima S

Bioscience, biotechnology, and biochemistry   Vol. 70 ( 6 ) page： 1492-5   2006.6

EBウイルスゲノム複製装置形成・成熟の分子基盤の解明

2017.8

医学系研究奨励 

食品中に含まれる化学物質が発がんウイルスEBVの増殖に与える影響の解析

2016.10 - 2017.3

医学研究・健康増進活動等助成 

佐藤好隆

CMV/EBVのウイルス後期遺伝子の転写を抑制する小分子の探索

2015.8 - 2017.3

GSKジャパン研究助成 

佐藤好隆

周囲の環境に応じた感染細胞の運命決定機構の解明

Grant number：19H04829  2019.4 - 2021.3

科学研究費助成事業  新学術領域研究(研究領域提案型)

佐藤 好隆

A genome-wide knockout screen identified host factors modulating herpes simplex virus infection

Grant number：16H06231  2016.4 - 2020.3

SATO Yoshitaka

Research for the mechanism of latency and immortalization of Epstein-Barr virus using haploid cells

Grant number：16K15525  2016.4 - 2018.3

Kimura Hiroshi